152 related articles for article (PubMed ID: 18308736)
41. In vitro effects of progesterone and the synthetic progestin medroxyprogesterone acetate on vascular remodeling.
Cutini PH; Massheimer VL
Mol Cell Endocrinol; 2019 Dec; 498():110543. PubMed ID: 31421164
[TBL] [Abstract][Full Text] [Related]
42. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
43. Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling.
Ma F; Zhang D; Yang H; Sun H; Wu W; Gan Y; Balducci J; Wei YQ; Zhao X; Huang Y
Genes Cells; 2009 Mar; 14(3):281-93. PubMed ID: 19267780
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
45. 17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange.
Hillebrand U; Hausberg M; Stock C; Shahin V; Nikova D; Riethmüller C; Kliche K; Ludwig T; Schillers H; Schneider SW; Oberleithner H
Cardiovasc Res; 2006 Mar; 69(4):916-24. PubMed ID: 16412402
[TBL] [Abstract][Full Text] [Related]
46. Angiostatin and plasminogen share binding to endothelial cell surface actin.
Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
[TBL] [Abstract][Full Text] [Related]
47. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
[TBL] [Abstract][Full Text] [Related]
48. T-cell-receptor-dependent actin regulatory mechanisms.
Huang Y; Burkhardt JK
J Cell Sci; 2007 Mar; 120(Pt 5):723-30. PubMed ID: 17314246
[TBL] [Abstract][Full Text] [Related]
49. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
50. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity.
Gamell C; Osses N; Bartrons R; Rückle T; Camps M; Rosa JL; Ventura F
J Cell Sci; 2008 Dec; 121(Pt 23):3960-70. PubMed ID: 19001503
[TBL] [Abstract][Full Text] [Related]
51. Effect of thrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation.
Cuerrier CM; Gagner A; Lebel R; Gobeil F; Grandbois M
J Mol Recognit; 2009; 22(5):389-96. PubMed ID: 19415761
[TBL] [Abstract][Full Text] [Related]
52. [Rho-kinase signaling pathway participates in endothelin-1-induced human airway smooth muscle cell migration and cytoskeletal reorganization].
Li ZX; Luo YL; Xu J; Ren DQ; Zhao YX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1031-4. PubMed ID: 18583257
[TBL] [Abstract][Full Text] [Related]
53. The effect of moesin overexpression on ageing of human dermal microvascular endothelial cells.
Lee JH; Hong IA; Oh SH; Kwon YS; Cho SH; Lee KH
Exp Dermatol; 2009 Nov; 18(11):997-9. PubMed ID: 19555429
[TBL] [Abstract][Full Text] [Related]
54. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
55. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
56. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability.
Guo X; Wang L; Chen B; Li Q; Wang J; Zhao M; Wu W; Zhu P; Huang X; Huang Q
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H238-46. PubMed ID: 19395553
[TBL] [Abstract][Full Text] [Related]
57. Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures.
Doulet N; Donnadieu E; Laran-Chich MP; Niedergang F; Nassif X; Couraud PO; Bourdoulous S
J Cell Biol; 2006 May; 173(4):627-37. PubMed ID: 16717131
[TBL] [Abstract][Full Text] [Related]
58. Moesin becomes linked to the plasma membrane in attached neutrophil granulocytes.
Keresztes M; Lajtos Z; Fischer J; Dux L
Biochem Biophys Res Commun; 1998 Nov; 252(3):723-7. PubMed ID: 9837773
[TBL] [Abstract][Full Text] [Related]
59. LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton.
Sanchez AM; Flamini MI; Russo E; Casarosa E; Pacini S; Petrini M; Genazzani AR; Simoncini T
Mol Cell Endocrinol; 2016 Dec; 437():22-34. PubMed ID: 27502036
[TBL] [Abstract][Full Text] [Related]
60. Differential regulation of endothelium behavior by progesterone and medroxyprogesterone acetate.
Cutini PH; Campelo AE; Massheimer VL
J Endocrinol; 2014 Mar; 220(3):179-93. PubMed ID: 24301615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
